Cite Filings / IMVT
Feed Companies Filings Check
Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Filings Insiders Search text
All 652 Financials 117 Shareholder Meetings 8 Executive Compensation 100 Insider Trading 359 Beneficial Ownership Interest 40 Business Combinations 88 Public Offerings 51 Mutual Funds and ETFs 7 Others 82
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2019-05-09
  3. 8-A12B Other Registration of Securities 2019-05-09
  4. CORRESP Other Correspondence Between Filers and SEC Staff 2019-05-08
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2019-05-03
  6. S-1/A Offering Registration Statement 2019-05-03
  7. UPLOAD Other SEC-generated Letter 2019-05-01
  8. S-1/A Offering Registration Statement 2019-04-29
  9. S-1 Offering Registration Statement 2019-04-16
  10. DRS/A Other Draft Registration Statement 2019-02-26
  11. DRSLTR Other Correspondence Related to Draft Registration Statement 2019-02-25
  12. UPLOAD Other SEC-generated Letter 2019-02-11
  13. DRS Other Draft Registration Statement 2019-01-23

Page 33 of 33 · 652 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…